Search

everythinglearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Hormone treatment before hypospadias surgery can increase penis size and reduce surgery complications.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Finasteride helps improve hair growth in men with hair loss but may increase the risk of erectile dysfunction.

Tailor treatments for vitiligo to patient needs for best results.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

Platelet-Rich Plasma (PRP) treatment may increase hair growth for genetic hair loss, but more research is needed to confirm this.

PRP improves hair thickness for both genders, but only increases hair density in men.

Melatonin improved secondary hair growth in goats but didn't affect primary hair density or litter size.

More research is needed to confirm if Platelet-Rich Plasma (PRP) is effective for treating hair loss.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

A hair wrapped tightly around an infant's toe caused severe damage, requiring early removal and possibly surgery to prevent worse outcomes like amputation.

PRP therapy increases hair density for androgenetic alopecia.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Finasteride's potential harms are hard to accurately measure.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

Only anti-androgenic drugs likely halt AGA progression.

Combining PRP with micro-needling improves hair growth and thickness in treating hair loss.

More research is needed to understand sex and racial differences in long COVID.

The September 2023 issue highlights the importance of safety in cosmetic procedures and updates on treatments for acne, rosacea, and hair restoration.

The editorial stresses the importance of COVID-19 vaccination and ongoing contributions to the journal.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Male-pattern baldness has a weak link to heart disease and some related health conditions.

The document covers various dermatological treatments and conditions.

Some plant extracts may treat livestock diseases, certain animal treatments are safe and effective, but more research on drug safety and resistance is needed.